HCA Healthcare Inc [HCA] stock prices are down -1.15% to $410.76 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HCA shares have gain 3.78% over the last week, with a monthly amount glided 1.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
HCA Healthcare Inc [NYSE: HCA] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $475. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on September 03, 2024, and set its price target to $427. On May 30, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $396 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $356 on March 06, 2024. Bernstein downgraded its rating to a Mkt Perform and raised its price target to $301 on January 04, 2024. Goldman downgraded its rating to Neutral for this stock on December 11, 2023, but kept the price target unchanged to $271. In a note dated April 21, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $304 on this stock.
The stock price of HCA Healthcare Inc [HCA] has been fluctuating between $215.96 and $417.14 over the past year. Currently, Wall Street analysts expect the stock to reach $304.4 within the next 12 months. HCA Healthcare Inc [NYSE: HCA] shares were valued at $410.76 at the most recent close of the market. An investor can expect a potential drop of -25.89% based on the average HCA price forecast.
Analyzing the HCA fundamentals
The HCA Healthcare Inc [NYSE:HCA] reported sales of 68.35B for trailing twelve months, representing a surge of 10.28%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is -3.07 and Total Capital is 0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -25.55.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 408.89 points at the first support level, and at 407.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 414.30, and for the 2nd resistance point, it is at 417.85.
Ratios To Look Out For
It’s worth pointing out that HCA Healthcare Inc [NYSE:HCA]’s Current Ratio is 1.06. As well, the Quick Ratio is 0.94, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 1.55 and price to earnings (TTM) ratio is 19.27.
Transactions by insiders
Recent insider trading involved Cuffe Michael S., EVP and Chief Clinical Officer, that happened on Sep 12 ’24 when 8358.0 shares were sold. Officer, Cuffe Michael S. completed a deal on Sep 12 ’24 to buy 8358.0 shares. Meanwhile, SVP & Chief Ethics Officer Whalen Kathleen M sold 2987.0 shares on Jul 31 ’24.
